Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: A focused safety analysis of ACTG PEARLS (A5175)
© 2014 Thomas Land Publishers, Inc. Background: Convenient dosing, potency, and low toxicity support use of tenofovir disoproxil fumarate (TDF) as preferred nucleotide reverse transcriptase inhibitor (NRTI) for HIV-1 treatment. However, renal and metabolic safety of TDF compared to other NRTIs has n...
Saved in:
Main Authors: | Touzard Romo,F., Smeaton,L.M., Campbell,T.B., Rivière,C., Mngqibisa,R., Nyirenda,M.J., Supparatpinyo,K., Kumarasamy,N., Hakim,J.G., Flanigan,T.P. |
---|---|
Format: | Article |
Published: |
Thomas Land Publishers Inc.
2015
|
Subjects: | |
Online Access: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84916201328&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38347 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated with Virologic Failure: Results from the Multinational PEARLS (ACTG A5175) Clinical Trial
by: Kantor R., et al.
Published: (2015) -
Herpes simplex virus type 2 acquisition among HIV-1-infected adults treated with Tenofovir disoproxyl fumarate as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study
by: Celum C., et al.
Published: (2017) -
Herpes simplex virus type 2 acquisition among HIV-1-infected adults treated with Tenofovir disoproxyl fumarate as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study
by: Connie Celum, et al.
Published: (2018) -
Herpes simplex virus type 2 acquisition among HIV-1-infected adults treated with Tenofovir disoproxyl fumarate as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study
by: Connie Celum, et al.
Published: (2018) -
Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial
by: Rupak Shivakoti, et al.
Published: (2018)